| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.45 | 0.005 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |